|
Appenheimer, Michelle M; Huang, Ruea-Yea; Chandrasekaran, E V et al. (2003) Biologic contribution of P1 promoter-mediated expression of ST6Gal I sialyltransferase. Glycobiology 13:591-600
|
|
Wuensch, S A; Huang, R Y; Ewing, J et al. (2000) Murine B cell differentiation is accompanied by programmed expression of multiple novel beta-galactoside alpha2, 6-sialyltransferase mRNA forms. Glycobiology 10:67-75
|
|
Dimitroff, C J; Pera, P; Dall'Olio, F et al. (1999) Cell surface n-acetylneuraminic acid alpha2,3-galactoside-dependent intercellular adhesion of human colon cancer cells. Biochem Biophys Res Commun 256:631-6
|
|
Dall'Olio, F; Chiricolo, M; Lau, J T (1999) Differential expression of the hepatic transcript of beta-galactoside alpha2,6-sialyltransferase in human colon cancer cell lines. Int J Cancer 81:243-7
|
|
Lo, N W; Dennis, J W; Lau, J T (1999) Overexpression of the alpha2,6-sialyltransferase, ST6Gal I, in a low metastatic variant of a murine lymphoblastoid cell line is associated with appearance of a unique ST6Gal I mRNA. Biochem Biophys Res Commun 264:619-21
|
|
Dalziel, M; Lemaire, S; Ewing, J et al. (1999) Hepatic acute phase induction of murine beta-galactoside alpha 2,6 sialyltransferase (ST6Gal I) is IL-6 dependent and mediated by elevation of exon H-containing class of transcripts. Glycobiology 9:1003-8
|
|
Lo, N W; Lau, J T (1999) Transcription of the beta-galactoside alpha2,6-sialyltransferase gene (SIAT1) in B-lymphocytes: cell type-specific expression correlates with presence of the divergent 5'-untranslated sequence. Glycobiology 9:907-14
|
|
Kalcheva, I; Elliott, R W; Dalziel, M et al. (1997) The gene encoding beta-galactoside alpha2,6-sialyltransferase maps to mouse chromosome 16. Mamm Genome 8:619-20
|
|
Hu, Y P; Dalziel, M; Lau, J T (1997) Murine hepatic beta-galactoside alpha 2,6-sialyltransferase gene expression involves usage of a novel upstream exon region. Glycoconj J 14:407-11
|
|
Dall'Olio, F; Mariani, E; Tarozzi, A et al. (1997) Expression of beta-galactoside alpha 2,6-sialyltransferase does not alter the susceptibility of human colon cancer cells to NK-mediated cell lysis. Glycobiology 7:507-13
|
Showing the most recent 10 out of 24 publications
